Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adequate Intake of Potassium Does Not Cause Hyperkalemia in Hypertensive Individuals on Medications That Antagonize the Renin Angiotensin Aldosterone System

NCT02759367 is registered in ClinicalTrials.gov with Samuel Lunenfeld Research Institute, Mount Sinai Hospital as lead sponsor.

NCT NCT02759367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02759367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adequate Intake of Potassium Does Not Cause Hyperkalemia in Hypertensive Individuals on Medications That Antagonize the Renin Angiotensin Aldosterone System
Lead sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2008
Completion date
June 30, 2015
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension